2013 annual financial data
Ascendis Pharma 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was 30.92%.
Operating income was 5,279,000 EUR and net income was 4,079,000 EUR.
Operating cash flow was 6,310,000 EUR.
Get free Ascendis Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20,408,000 EUR
- Operating income
- 5,279,000 EUR
- Net income
- 4,079,000 EUR
- Operating cash flow
- 6,310,000 EUR